Loading data for OBX — first visit, this takes a few seconds.

Obsidian Therapeutics Inc...

NasdaqCM: OBX · 실시간 가격 · USD
19.95
+2.41 (13.74%)
종가 기준: Aug 19, 2026, 3:59 PM

Obsidian Therapeutics Inc. (OBX) Stock Price, Analysis & Data

13.74%
매수호가n/a
시가총액1.24B
매출 (ttm)n/a
순이익 (ttm)-95.25M
베타2.64
EPS (ttm)-1.56
P/E (ttm)n/a
선행 P/E-9.39
P/B (ttm)-1.53
P/S (ttm)n/a
Earnings Daten/a
매도호가n/a
거래량112,138
평균 거래량 (20일)35,682
시가19.26
전일 종가17.54
일중 범위17.12 - 20.19
52주 범위14.57 - 49.97
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

OBX 소개

Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-appro...

섹터 Healthcare
IPO 일자 Jul 27, 2026
직원 수 71
상장 거래소 NasdaqCM
티커 OBX
전체 기업 정보

재무 실적

2025년 Obsidian Therapeutics의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -100.61M로, 21.05% 증가했습니다.

재무제표